Chlamydial cervicitis: Testing the practice guidelines for presumptive diagnosis

CMAJ. Canadian Medical Association Journal

Volumn 158, Issue 1, 1998, Pages 41-46

  Sellors, John ^a,b   Howard, Michelle ^b   Pickard, Laura ^a   Jang, Dan ^b   Mahony, James ^a,b   Chernesky, Max ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CANADA; CHLAMYDIA TRACHOMATIS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EDEMA; ERYTHEMA; FAMILY PLANNING; FEMALE; GRAM STAINING; HUMAN; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; NEUTROPHIL; PRACTICE GUIDELINE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY;

EID: 0032512445     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Davies HD, Wang EL with the Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Can Med Assoc J 1996;154:1631-44.
2. Westrom L. Influence of sexually transmitted diseases on sterility and ectopic pregnancy. Acta Eur Fertil 1985;16(1):21-4.
3. Scholes D, Stergachis A, Heidrich F, Andrilla H, Holmes K, Stamm W. Prevention of pelvic inflammatory disease by screening for chlamydial infection. N Engl J Med 1996;334:1362:-6.
4. Sellors JW, Mahony JB, Chernesky MA, Rath DJ. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis. Fertil Steril 1988;49(3):451-7.
5. Brunham RC, MacLean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985;152:1275-82.
6. Brunham RC, Binns B, Guijon F, Danforth D, Kosseim ML, Rand F, et al. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis 1988; 158(3):510-7.
7. Sellors JW, Pickard L, Gafni A, Goldsmith CH, Jang D, Mahony J, et al. Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. Arch Intern Med 1992;152:1837-44.
8. Canadian STD guidelines, 1995 update. Can Commun Dis Rep 1995;21S4 (suppl).
9. Brunham RC, Paavonen J, Stevens CE, Kiviat N, Kuo CC, Critchlow CW, et al. Mucopurulent cervicitis - the ignored counterpart in women of urethritis in men. N Engl J Med 1984;311:1-6.
10. Moscicki B, Shafer MA, Millstein SG, Irwin CE, Schachter J. The use and limitations of endocervical Gram stains and mucopurulent cervicitis as predictors for Chlamydia trachomatis in female adolescents. Am J Obstet Gynecol 1987; 157(1):65-71.
11. Nugent RP, Hillier SL. Mucopurulent cervicitis as a predictor of a chlamydial infection and adverse pregnancy outcome. Sex Transm Dis 1992;19(4):198-202.
12. Sellors JW, Mahony JB, Jang D, Pickard L, Goldsmith CH, Gafni A, et al. Comparison of cervical, urethral, and urine specimens for the detection of Chlamydia trachomatis in women. J Infect Dis 1991;164:205-8.
13. Spence MR, Hollander DH, Smith J, McCaig L, Sewell D, Brockman M. The clinical and laboratory diagnosis of Trichomonas vaginalis infection. Sex Transm Dis 1980;7(4):168-71.
14. Spiegel CA, Amsel R, Kolmes K. Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid. J Clin Microbiol 1983;18(1):170-7.
15. Fleiss JL. The measurement of interrater agreement. In: Statistical methods for rates and proportions. Toronto: John Wiley and Sons; 1981. p. 211-36.
16. Sackett DL, Haynes RB, Tugwell P. The interpretation of diagnostic data. In: Clinical epidemiology: a basic science for clinical medicine. Toronto: Little, Brown and Company; 1985. p. 59-138.
17. Massé R, Laperrière H, Rousseau H, Lefebvre J, Remis RS. Chlamydia trachomatis cervical infection: prevalence and determinants among women presenting for routine gynecologic examination. Can Med Assoc J 1991;145(8):953-61.
18. Harrison HR, Costin M, Meder JB, Bownds LM, Sim DA, Lewis M, et al. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervcitis. Am J Obstet Gynecol 1985;153:244-51.
19. Johnson BA, Poses RM, Fortner CA, Meier FA, Dalton HP. Derivation and validation of a clinical diagnostic model for chlamydial cervical infection in university women. JAMA 1990;264:3161-5.
20. Haddix AC, Hillis SD, Kassler WJ. The cost-effectiveness of azithromycin for Chlamydia trachomatis infections on women. Sex Transm Dis 1995;22(5):274-80.
21. Forbes BA, Bartholoma N, McMillan J, Roefaro M, Weiner L, Welych L. Evaluation of a monoclonal antibody test to detect chlamydia in cervical and urethral specimens. J Clin Microbiol 1986;23(6):1136-7.
22. Hall CJ, Nedler C. Comparison of three non-culture techniques for detection of Chlamydia trachomatis in genital tract specimens. Eur J Clin Microbiol Infect Dis 1989;8(10):866-70.
23. Scheel O, Anestad G, Mundal R, Berdal BP. Detection of Chlamydia trachomatis in the urine of young Norwegian males by enzyme immunoassay. Eur J Clin Microbiol Infect Dis 1993;12(10):746-49.
24. Hayward RSA, Laupacis A. Initiating, conducting and maintaining guidelines development programs. Can Med Assoc J 1993;148(4):507-12.
25. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR 1993;42(RR-12):1-39.